Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 25, 2017 - Issue 1
Submit an article Journal homepage
439
Views
31
CrossRef citations to date
0
Altmetric
Original Articles

Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis

Murat HasanreisogluDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, TurkeyCorrespondence[email protected]
, MD,
Mehmet Ozgur CubukDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey
, MD,
Sengul OzdekDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey
, MD,
Gokhan GurelikDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey
, MD,
Zeynep AktasDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey
, MD &
Berati HasanreisogluDepartment of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey
, MD
Pages 71-75 | Received 27 Apr 2014, Accepted 14 Dec 2015, Published online: 24 Feb 2016

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Carla Gaggiano, Jurgen Sota, Stefano Gentileschi, Valeria Caggiano, Salvatore Grosso, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2020) The current status of biological treatment for uveitis. Expert Review of Clinical Immunology 16:8, pages 787-811.
Read now
Xiaoli Liu, Maria Diedrichs-Möhring & Gerhild Wildner. (2019) The Role of IFN-alpha in Experimental and Clinical Uveitis. Ocular Immunology and Inflammation 27:1, pages 23-33.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Ilknur Tugal-Tutkun, Moncef Khairallah, Annabelle A. Okada, Bahram Bodaghi & Manfred Zierhut. (2017) Behçet Uveitis. Ocular Immunology and Inflammation 25:1, pages 2-6.
Read now

Articles from other publishers (28)

Biao Li, Haoran Li, Qun Huang & Yanlin Zheng. (2023) Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies. Ophthalmology and Therapy.
Crossref
George E. Fragoulis, George Bertsias, Bahram Bodaghi, Ahmet Gul, Jan van Laar, Gonca Mumcu, David Saadoun, Ilknur Tugal-Tutkun, Gulen Hatemi & Petros P. Sfikakis. (2023) Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?. Clinical Immunology 246, pages 109186.
Crossref
Xue Wu, Mengying Tao, Ling Zhu, Ting Zhang & Ming Zhang. (2022) Pathogenesis and current therapies for non-infectious uveitis. Clinical and Experimental Medicine 23:4, pages 1089-1106.
Crossref
Shereen H. Aboul Naga, Lameece Moustafa Hassan, Radwa T. El Zanaty, Mohammad Refaat, Rana H. Amin, Gaafar Ragab & Mahmoud M. Soliman. (2022) Behçet uveitis: Current practice and future perspectives. Frontiers in Medicine 9.
Crossref
Simple GuptaK. ShyamsundarMohini Agrawal, Nitin VichareJyotirmay Biswas. (2022) Current Knowledge of Biologics in Treatment of Noninfectious Uveitis. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 203-222.
Crossref
Hanna Zając & Anna Turno-Kręcicka. (2021) Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management. Journal of Clinical Medicine 10:21, pages 5174.
Crossref
Yujing Qian, Yi Qu, Fei Gao, Minghang Pei, Anyi Liang, Junyan Xiao, Chan Zhao & Meifen Zhang. (2021) Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study. Frontiers in Pharmacology 12.
Crossref
Sang-Wan Chung. (2021) Vasculitis: From Target Molecules to Novel Therapeutic Approaches. Biomedicines 9:7, pages 757.
Crossref
Perpetual Uke, Rachel Gorodkin & Nicholas Beare. (2020) Biologic therapy for Behçet’s uveitis: a systematic review. British Journal of Ophthalmology 104:8, pages 1045-1051.
Crossref
Martina Bonacini, Alessandra Soriano, Luca Cimino, Luca De Simone, Elena Bolletta, Fabrizio Gozzi, Francesco Muratore, Maria Nicastro, Lucia Belloni, Alessandro Zerbini, Luigi Fontana, Carlo Salvarani & Stefania Croci. (2020) Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases. Frontiers in Immunology 11.
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis 73 102 .
Xia Ni Wu, Lazha Ahmed Talat Sharief, Roy Schwartz, Þóra Elísabet Jónsdóttir, Anastasia Tasiopoulou, Ahmed Al-Janabi, Noura Al Qassimi, Amgad Mahmoud, Sue Lightman & Oren Tomkins-Netzer. 2020. Current Concepts in Ophthalmology. Current Concepts in Ophthalmology 121 140 .
Vedat Hamuryudan, Ina Kötter & Hasan Tüzün. 2020. Behçet Syndrome. Behçet Syndrome 279 305 .
Changying Jing, Zhuolun Sun, Xiaofeng Xie, Xiuyan Zhang, Shanshan Wu, Keying Guo & Hongsheng Bi. (2019) Network pharmacology-based identification of the key mechanism of Qinghuo Rougan Formula acting on uveitis. Biomedicine & Pharmacotherapy 120, pages 109381.
Crossref
Mohammad Ali Shahab, Tahreem Aman Mir & Sidra Zafar. (2018) Optimising drug therapy for non-infectious uveitis. International Ophthalmology 39:7, pages 1633-1650.
Crossref
I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia & M. Khairallah. (2019) Œil et maladie de Behçet. Journal Français d'Ophtalmologie 42:6, pages 626-641.
Crossref
Akshay S. Thomas. (2019) Biologics for the treatment of noninfectious uveitis. Current Opinion in Ophthalmology 30:3, pages 138-150.
Crossref
I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia & M. Khairallah. (2019) Eye and Behçet's disease. Journal Français d'Ophtalmologie 42:4, pages e133-e146.
Crossref
Hande CelikerHaluk KazokogluHaner Direskeneli. (2019) Factors Affecting Relapse and Remission in Behçet's Uveitis Treated with Interferon Alpha2a. Journal of Ocular Pharmacology and Therapeutics 35:1, pages 58-65.
Crossref
Jing Shi, Chan Zhao, Jiaxin Zhou, Jinjing Liu, Li Wang, Fei Gao, Xiaofeng Zeng, Meifen Zhang & Wenjie Zheng. (2019) Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis. Therapeutic Advances in Chronic Disease 10, pages 204062231984788.
Crossref
Shilpa Kodati & Christina Y. Weng. (2019) Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis. International Ophthalmology Clinics 59:1, pages 111-126.
Crossref
Ana Urruticoechea-Arana, Tatiana Cobo-Ibáñez, Virginia Villaverde-García, Montserrat Santos Gómez, Estíbaliz Loza, Kelly Vargas-Osorio, Leslie Fariñas Padrón, Federico Diaz-Gonzalez, Vanesa Calvo-Río & Ricardo Blanco. (2018) Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review. Rheumatology International 39:1, pages 47-58.
Crossref
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis 175 207 .
Ji Hwan Lee, Christopher Seungkyu Lee & Sung Chul Lee. (2018) Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients. BMC Ophthalmology 18:1.
Crossref
Fatma Alibaz-Oner, Amr H. Sawalha & Haner Direskeneli. (2018) Management of Behçet's disease. Current Opinion in Rheumatology 30:3, pages 238-242.
Crossref
Alejandro Gómez-Gómez, Estíbaliz Loza, Maria Piedad Rosario, Gerard Espinosa, José M. García Ruiz de Morales, Jose M. Herreras, Santiago Muñoz-Fernández & Miguel Cordero-Coma. (2017) Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis. Medicine 96:42, pages e8045.
Crossref
Merih OraySumru OnalGunay UludagAylin Koc AkbayIlknur Tugal-Tutkun. (2017) Interferon Alpha for the Treatment of Cystoid Macular Edema Associated with Presumed Ocular Tuberculosis. Journal of Ocular Pharmacology and Therapeutics 33:4, pages 304-312.
Crossref
. (2017) Azathioprine/ciclosporin/interferon α 2a. Reactions Weekly 1648:1, pages 60-60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.